Brandon Drafts, MD
Interventional Cardiology · West Columbia, SCNPI 1336309095
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,756 of the $11,057 with a category attached, or 88.2%. 39 manufacturers reported payments, led by Abbott at 30.8% of the total. Reporting peaked in 2024 at $2,556 and has fallen 51.1% since, to $1,251 in 2025.
Across 501 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Inari Medical, Inc.$1K
- Medtronic$1K
- Boston Scientific$944
- Novartis$818
- Edwards Lifesciences$473
- plus $3K from 33 others
Across 8 payments — averaging $1721.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$10K
- EKOS Corporation$4K
What the payments were for
- Travel & lodging$1,26511%
- Food & beverage$9,75688%
- Education$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 53 | $3,408 |
| Inari Medical, Inc. | 140 | $1,376 |
| Medtronic(2 entities) | 43 | $1,255 |
| Boston Scientific | 27 | $944 |
| Novartis | 51 | $818 |
| Edwards Lifesciences | 18 | $473 |
| E.r. Squibb & Sons, L.L.C. | 27 | $297 |
| Abiomed | 3 | $267 |
| Stryker | 29 | $266 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $253 |
| AstraZeneca | 17 | $209 |
| Pfizer | 11 | $177 |
| Amgen | 8 | $140 |
| Shockwave Medical, Inc | 3 | $120 |
| Sanofi-aventis U.S. LLC | 7 | $113 |
| Chiesi USA, Inc. | 7 | $107 |
| Regeneron Healthcare Solutions, Inc. | 5 | $76 |
| Cardiovascular Systems Inc. | 6 | $71 |
| Daiichi Sankyo Inc. | 3 | $66 |
| Philips North America LLC | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Novo Nordisk | 2 | $56 |
| Bridgebio Pharma, Inc. | 2 | $49 |
| Biotronik Inc. | 3 | $47 |
| Johnson & Johnson | 4 | $45 |
| Irhythm Technologies, Inc. | 2 | $41 |
| Angiodynamics, Inc. | 2 | $41 |
| BD | 1 | $28 |
| Merck | 2 | $27 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Cordis US CORP. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Atricure, Inc. | 1 | $17 |
| EKOS Corporation | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$617
- Mitra Clip system$490
- FLOWTRIEVER CATHETER, S$401
- CT THROMBECTOMY SYSTEM KIT$401
- AVVIGO Guidance System$270
- MitraClip System$228
- Micra$207
- ONYX FRONTIER$154
- COMET$141
- SAPIEN 3 Ultra RESILIA$130
- AZURE XT DR MRI SURESCAN$111
- Impella$108
How this compares
$11,057 in reported general payments places this provider in the 55th percentile of 117 interventional cardiology providers in South Carolina.
See all interventional cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 294 | $319,243 |
| EntrestoSacubitril/Valsartan | 55 | $69,992 |
| BrilintaTicagrelor | 123 | $57,743 |
| XareltoRivaroxaban | 44 | $40,769 |
| JardianceEmpagliflozin | 31 | $29,624 |
| FarxigaDapagliflozin Propanediol | 16 | $20,235 |
| Metoprolol Succinate | 302 | $5,144 |
| Rosuvastatin Calcium | 186 | $4,089 |
| Flecainide Acetate | 49 | $2,357 |
| Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine | 11 | $1,918 |
| ClopidogrelClopidogrel Bisulfate | 116 | $1,887 |
| Ezetimibe | 27 | $1,884 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 66 | $1,662 |
| Carvedilol | 163 | $1,625 |
| Atorvastatin Calcium | 136 | $1,620 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $177 | $319,243294 claims |
| AstraZenecaBrilinta, Farxiga | $209 | $77,978139 claims |
| NovartisEntresto | $818 | $69,99255 claims |
| Johnson & JohnsonXarelto | $45 | $40,76944 claims |
| Boehringer IngelheimJardiance | $17 | $29,62431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 117 interventional cardiology providers in South Carolina.
Other interventional cardiology in West Columbia
- Robert LeonardiWest Columbia$203K
- Christopher PerryWest Columbia$26K
- Robert MalanukWest Columbia$25K
- Gregory GiuglianoWest Columbia$25K
- Garrett RuthWest Columbia$14K
- Jonathan HewettWest Columbia$11K
- William BrearleyWest Columbia$10K
- Brian WallWest Columbia$10K
- Daniel SteinbergCharleston$611K
- Brian BrownSpartanburg$389K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.